Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
Spence
R K
RK
Dept. of Surgery, Cooper Hospital/University Medical Center, Camden, NJ 08103.
McCoy
S
S
Costabile
J
J
Norcross
E D
ED
Pello
M
M
Alexander
J
J
Atabek
U
U
Wisdom
C
C
Camishion
R
R
D000740:Anemia / Q000097:blood / Q000628:therapy*; D001802:Blood Substitutes / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D005466:Fluorocarbons / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D010100:Oxygen / Q000097:blood
D001802:Blood Substitutes; D004338:Drug Combinations; D005466:Fluorocarbons; D006895:Hydroxyethyl Starch Derivatives; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination; D010100:Oxygen